USPTO serial 86754342
VIVOSIM
Reviewed by CopyMark Law Group
Reg. 5148917Status 710
- Filing date
- Status date
- Registration date
- Feb 28, 2017
- Examiner
- HUNT, LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with VIVOSIM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
PRESTON SMIRMAN
PRESTON SMIRMAN Smirman Ip Law Pllc116 Terry AveRochester, MI 48307-1570UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software for use in drug dosing in the field of drug development; Computer software for use in drug dosing in the field of drug development; Software for the prediction of drug efficiency; Computer software for the prediction of drug efficiency | SECTION 8 - CANCELLED | — |
| 042 | Advisory services in the field of product development and quality improvement of software; Advisory services in the field of product development and quality improvement of software for the prediction of drug efficiency; Advisory services in the field of software design; Advisory services in the field of software design for software for the prediction of drug efficiency; Advisory services relating to software; Advisory services relating to software for the prediction of drug efficiency; Consulting and advisory services in the field of software; Consulting and advisory services in the field of software for the prediction of drug efficiency; Design of software; Design of computer software; Design of software for the prediction of drug efficiency; Design of computer software for the prediction of drug efficiency; Design services for software; Design services for computer software; Design services for software for the prediction of drug efficiency; Design services for computer software for the prediction of drug efficiency; Development of software; Development of computer software; Development of software for the prediction of drug efficiency; Development of computer software for the prediction of drug efficiency; Concept design and development of software for others; Concept design and development of computer software for others; Concept design and development of software for the prediction of drug efficiency for others; Concept design and development of computer software for the prediction of drug efficiency; Programming of software for others; Programming of software for the prediction of drug efficiency for others; Implementation of software; Implementation of software for the prediction of drug efficiency; Maintenance of software; Maintenance of software for the prediction of drug efficiency; Servicing of software, namely, updating and maintaining software for others; Servicing of software, namely, updating and maintaining software for others for the prediction of drug efficiency; Adaptation of software, namely, customization of software for others; Adaptation of software, namely, updating and maintaining software for others for the prediction of drug efficiency; Professional consultancy services relating to software creation; Professional consultancy services relating to software creation for software for the prediction of drug efficiency; Installation of software; Installation of software for the prediction of drug efficiency; Conception design and development of software for others; Conception design and development of software for others for the prediction of drug efficiency; Custom design of software packages; Custom design of software packages for the prediction of drug efficiency; Custom structuring, namely, design of software packages; Custom structuring, namely, design of software packages for the prediction of drug efficiency; Software engineering; Software engineering of software for the prediction of drug efficiency; Software creation; Software creation of software for the prediction of drug efficiency; Software customization; Software customization of software for the prediction of drug efficiency; Technical support in the field of software, namely, troubleshooting software problems; Technical support in the field of software for the prediction of drug efficiency, namely, troubleshooting software problems; Rental of software; Rental of computer software; Rental of software for the prediction of drug efficiency; Rental of computer software for the prediction of drug efficiency; Updating of software; Updating of software for the prediction of drug efficiency; Updating of computer software; Updating of computer software for the prediction of drug efficiency; Pharmaceutical drug development services, namely, prediction of drug efficiency and prediction of drug efficiency to optimize medical treatment | SECTION 8 - CANCELLED | — |
| 045 | Licensing of software; Licensing of software for the prediction of drug efficiency | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ENMODES GMBH
- Other trademarks owned by ENMODES GMBH
- Other trademarks owned by ENMODES GMBH
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named VIVOSIM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2023 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Feb 28, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 28, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 13, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 13, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 23, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 4, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 26, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 26, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 26, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 26, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 26, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 5, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 5, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 12, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 12, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 2016 | ALIE | ASSIGNED TO LIE | — |
| Apr 25, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2015 | NWAP | NEW APPLICATION ENTERED | — |